STANDARD BIOTOOLS INC. - COMMON STOCK

Standard BioTools Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

21 2 2023 05:30:16 提供 Nasdaq GlobeNewswire

Standard BioTools Reports Fourth Quarter and Full Year 2022 Financial Results and Provides 2023 Business Outlook

14 2 2023 13:05:03 提供 Nasdaq GlobeNewswire

Standard BioTools Announces Conference Call and Webcast for Fourth Quarter and Full Year 2022 Financial Results

31 1 2023 05:30:53 提供 Nasdaq GlobeNewswire

Standard BioTools Provides Preliminary Fourth Quarter 2022 Revenue and Business Update

09 1 2023 05:30:02 提供 Nasdaq GlobeNewswire

Standard BioTools Announces Appointment of Betsy Jensen as Chief Human Resources Officer

03 1 2023 05:30:59 提供 Nasdaq GlobeNewswire

Standard BioTools Authorizes up to $20 Million of Share Repurchases

28 11 2022 05:30:00 提供 Nasdaq GlobeNewswire

Standard BioTools Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

22 11 2022 06:20:03 提供 Nasdaq GlobeNewswire

Standard BioTools Announces Third Quarter 2022 Financial Results

08 11 2022 13:05:02 提供 Nasdaq GlobeNewswire

Standard BioTools and Visiopharm Announce Partnership for the Development of Complete Image Analysis Solutions to be Packaged With Hyperion and Hyperion+ Imaging Systems

07 11 2022 13:05:02 提供 Nasdaq GlobeNewswire

Standard BioTools Announces Conference Call and Webcast of Third Quarter 2022 Financial Results

25 10 2022 05:30:01 提供 Nasdaq GlobeNewswire

Ascendas Genomics Receives NMPA Approval for Use of Standard BioTools Microfluidics Technology to Advance the Development of Molecular Diagnostics in China

13 10 2022 05:30:01 提供 Nasdaq GlobeNewswire

Standard BioTools Releases the X9 Real-Time PCR System, Its Most Productive and Flexible High-Capacity Genomics Platform

06 10 2022 05:30:01 提供 Nasdaq GlobeNewswire

Standard BioTools Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

25 8 2022 13:05:00 提供 Nasdaq GlobeNewswire

Standard BioTools Announces Second Quarter 2022 Financial Results and Provides Strategic Update

08 8 2022 13:02:00 提供 Nasdaq GlobeNewswire

Standard BioTools Announces Conference Call and Webcast of Second Quarter 2022 Financial Results

25 7 2022 13:30:00 提供 Nasdaq GlobeNewswire

Standard BioTools Announces First Quarter 2022 Financial Results

05 5 2022 13:02:00 提供 Nasdaq GlobeNewswire

Standard BioTools Announces Conference Call and Webcast of First Quarter 2022 Financial Results

22 4 2022 13:02:00 提供 Nasdaq GlobeNewswire

Standard BioTools Launches Hyperion+ Imaging System, the New Standard in High-Plex Spatial Imaging

11 4 2022 05:30:00 提供 Nasdaq GlobeNewswire

Standard BioTools Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

05 4 2022 16:15:24 提供 Nasdaq GlobeNewswire

Fluidigm Completes $250 Million Strategic Capital Infusion and Changes Name to Standard BioTools Inc.

04 4 2022 14:30:57 提供 Nasdaq GlobeNewswire